AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MHRA greenlights Advanced Cell Technology's human embryonic stem cell study.
(From Pharma)
M2PHARMA-September 23, 2011-MHRA greenlights Advanced Cell Technology's human embryonic stem cell study (C)2011 M2 COMMUNICATIONS http://www.m2.com
23 September 2011 - US Advanced Cell Technology Inc (OTCBB:ACTC) said on Thursday that it had been cleared by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to start treating patients as part of a Phase I/II study for Stargardt's Macular Dystrophy (SMD) using retinal pigment epithelium (RPE) derived from human embryonic stem cells (hESCs).
The company further said it had obtained a similar authorisation from the Gene Therapy Advisory …
-
- Advanced Cell Technology awarded federal grant from National Institutes of...
-
News wire article from: Chemical Business Newsbase
January 16, 2007
700+ words
-
- Advanced Cell Technology and CHA Bio & Diostech to collaborate on RPE...
-
News wire article from: Chemical Business Newsbase
March 30, 2009
700+ words
-
- Advanced Cell Technology announces 2010 results.(Financial report)
-
News wire article from: Chemical Business Newsbase
March 21, 2011
700+ words
-
- Advanced Cell Technology announces 2009 results.
-
News wire article from: Chemical Business Newsbase
March 17, 2010
700+ words
-
- Advanced Cell Technology obtains broad patent covering use of stem...
-
News wire article from: Chemical Business Newsbase
September 14, 2010
700+ words
